McCarthy S, Wilton L, Murray M, et al (2012). The epidemiology of pharmacological treatments for attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...
Elite received approval from the Food and Drug Administration for a generic version of Vyvanse (lisdexamfetamine dimesylate) capsules in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg ...
Symptoms of adult ADHD are generally treated with medicine. But there's more to effective treatment than just taking a pill. If you are one of the estimated 8.7 million American adults with ADHD ...
Introduction Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and is a persistent pattern of inattention and ...
Attention deficit hyperactivity disorder (ADHD) affects around 1–3% of children ... However, the designs used so far have not been able to show that these are definite causes of ADHD. For example, ...
Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...